374 related articles for article (PubMed ID: 19061221)
1. Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.
Buizer AI; de Sonneville LM; Veerman AJ
Pediatr Blood Cancer; 2009 Apr; 52(4):447-54. PubMed ID: 19061221
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
4. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
5. Scholarly literature review: management of neurocognitive late effects with stimulant medication.
Daly BP; Brown RT
J Pediatr Psychol; 2007 Oct; 32(9):1111-26. PubMed ID: 17442692
[TBL] [Abstract][Full Text] [Related]
6. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Buizer AI; De Sonneville LM; van den Heuvel-Eibrink MM; Njiokiktjien C; Veerman AJ
J Int Neuropsychol Soc; 2005 Sep; 11(5):554-65. PubMed ID: 16212682
[TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia.
Jain N; Brouwers P; Okcu MF; Cirino PT; Krull KR
Cancer; 2009 Sep; 115(18):4238-45. PubMed ID: 19536898
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors.
Duffner PK
Neurologist; 2004 Nov; 10(6):293-310. PubMed ID: 15518596
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment.
Janzen LA; Spiegler BJ
Dev Disabil Res Rev; 2008; 14(3):185-95. PubMed ID: 18924154
[TBL] [Abstract][Full Text] [Related]
11. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
Cole PD; Kamen BA
Ment Retard Dev Disabil Res Rev; 2006; 12(3):174-83. PubMed ID: 17061283
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia.
Peterson CC; Johnson CE; Ramirez LY; Huestis S; Pai AL; Demaree HA; Drotar D
Pediatr Blood Cancer; 2008 Jul; 51(1):99-104. PubMed ID: 18322925
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Cancer; 2006 May; 106(9):2067-75. PubMed ID: 16568441
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive effects of treatment for childhood cancer.
Butler RW; Haser JK
Ment Retard Dev Disabil Res Rev; 2006; 12(3):184-91. PubMed ID: 17061287
[TBL] [Abstract][Full Text] [Related]
16. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
17. Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only.
Kingma A; van Dommelen RI; Mooyaart EL; Wilmink JT; Deelman BG; Kamps WA
J Pediatr; 2001 Sep; 139(3):413-20. PubMed ID: 11562622
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychologic sequelae in the long-term survivors of childhood acute lymphoblastic leukemia.
Cetingül N; Aydinok Y; Kantar M; Oniz H; Kavakli K; Yalman O; Erermiş S; Celebisoy N; Akyürekli O; Oztop S; Nişli G
Pediatr Hematol Oncol; 1999; 16(3):213-20. PubMed ID: 10326219
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
20. Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.
Harila-Saari AH; Huuskonen UE; Tolonen U; Vainionpää LK; Lanning BM
Med Pediatr Oncol; 2001 Mar; 36(3):345-51. PubMed ID: 11241435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
